Patents by Inventor Nedjad LOSIC

Nedjad LOSIC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW DOSAGE REGIMENS FOR ANTIBODY DRUG CONJUGATES BASED ON ANTI-AXL ANTIBODIES
    Publication number: 20190233522
    Abstract: An antibody-drug conjugate (ADC) based on an antibody binding to human AXL and pharmaceutical compositions comprising the ADC for use in the treatment of a cancer comprising administering to a subject a weekly dose of from about 0.45 mg/kg to about 2.0 mg/kg of the ADC once a week for three consecutive weeks followed by a one week resting period without any administration of the ADC so that each cycle time is 28 days including the resting period.
    Type: Application
    Filed: July 7, 2017
    Publication date: August 1, 2019
    Inventors: Ulf FORSSMANN, Steen LISBY, Nedjad LOSIC